Raymond James Financial Services Advisors Inc. Increases Stock Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Raymond James Financial Services Advisors Inc. boosted its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Rating) by 5.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 41,507 shares of the company’s stock after acquiring an additional 2,020 shares during the period. Raymond James Financial Services Advisors Inc.’s holdings in Acadia Healthcare were worth $3,417,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ACHC. Crossmark Global Holdings Inc. increased its stake in Acadia Healthcare by 1.6% in the fourth quarter. Crossmark Global Holdings Inc. now owns 8,049 shares of the company’s stock valued at $663,000 after purchasing an additional 123 shares during the period. State of Alaska Department of Revenue increased its stake in Acadia Healthcare by 1.0% in the fourth quarter. State of Alaska Department of Revenue now owns 12,734 shares of the company’s stock valued at $1,048,000 after purchasing an additional 125 shares during the period. Eudaimonia Partners LLC increased its stake in Acadia Healthcare by 1.5% in the fourth quarter. Eudaimonia Partners LLC now owns 9,097 shares of the company’s stock valued at $749,000 after purchasing an additional 135 shares during the period. SPC Financial Inc. increased its stake in Acadia Healthcare by 1.1% in the fourth quarter. SPC Financial Inc. now owns 14,050 shares of the company’s stock valued at $1,157,000 after purchasing an additional 149 shares during the period. Finally, AE Wealth Management LLC increased its stake in Acadia Healthcare by 1.8% in the fourth quarter. AE Wealth Management LLC now owns 9,650 shares of the company’s stock valued at $794,000 after purchasing an additional 174 shares during the period. 99.79% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

ACHC has been the topic of a number of recent research reports. Mizuho dropped their price objective on shares of Acadia Healthcare from $87.00 to $80.00 and set a “neutral” rating on the stock in a research note on Monday, March 6th. Stephens dropped their price target on shares of Acadia Healthcare from $92.00 to $88.00 and set an “equal weight” rating on the stock in a research note on Wednesday, March 1st. Cantor Fitzgerald began coverage on shares of Acadia Healthcare in a research note on Thursday, April 20th. They set a “neutral” rating and a $83.00 price target on the stock. StockNews.com began coverage on shares of Acadia Healthcare in a research note on Thursday. They set a “hold” rating on the stock. Finally, Credit Suisse Group boosted their price target on shares of Acadia Healthcare to $95.00 in a research note on Thursday, May 4th. One analyst has rated the stock with a sell rating, four have given a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Acadia Healthcare currently has a consensus rating of “Hold” and an average target price of $89.10.

Acadia Healthcare Trading Up 0.8 %

Shares of ACHC opened at $72.54 on Monday. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 0.49. The firm’s 50-day moving average is $71.59 and its two-hundred day moving average is $78.25. Acadia Healthcare Company, Inc. has a twelve month low of $63.20 and a twelve month high of $89.85. The firm has a market capitalization of $6.68 billion, a P/E ratio of 23.78, a PEG ratio of 1.60 and a beta of 1.31.

Acadia Healthcare (NASDAQ:ACHC – Get Rating) last issued its earnings results on Monday, February 27th. The company reported $0.70 earnings per share for the quarter, missing the consensus estimate of $0.74 by ($0.04). Acadia Healthcare had a return on equity of 10.22% and a net margin of 10.32%. The company had revenue of $675.30 million for the quarter, compared to analyst estimates of $659.17 million. On average, research analysts predict that Acadia Healthcare Company, Inc. will post 3.23 earnings per share for the current fiscal year.

About Acadia Healthcare

(Get Rating)

Acadia Healthcare Co, Inc engages in the provision of behavioral healthcare services. It operates through the following business segments: United States (U.S.) Facilities and the United Kingdom (U.K.) Facilities. The U.S. Facilities segment is classified in the following categories: acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, and outpatient community-based services.